Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

Ablation of endothelial VEGFR1 improves metabolic dysfunction by inducing adipose tissue browning.

Seki T, Hosaka K, Fischer C, Lim S, Andersson P, Abe M, Iwamoto H, Gao Y, Wang X, Fong GH, Cao Y.

J Exp Med. 2018 Feb 5;215(2):611-626. doi: 10.1084/jem.20171012. Epub 2018 Jan 5.

PMID:
29305395
2.

VEGFR1 promotes cell migration and proliferation through PLCγ and PI3K pathways.

Weddell JC, Chen S, Imoukhuede PI.

NPJ Syst Biol Appl. 2017 Dec 19;4:1. doi: 10.1038/s41540-017-0037-9. eCollection 2018.

3.

Flt-1-positive cells are cancer-stem like cells in colorectal carcinoma.

Huang Y, Huang Y, Liu D, Wang T, Bai G.

Oncotarget. 2017 Jul 19;8(44):76375-76384. doi: 10.18632/oncotarget.19403. eCollection 2017 Sep 29.

4.

Vascular endothelial growth receptor 1 acts as a stress-associated protein in the therapeutic response to thalidomide.

Liu Q, Yin T, Wang G, Guo F, Ou Y, Li Y, Wang Y.

Exp Ther Med. 2017 Nov;14(5):4263-4271. doi: 10.3892/etm.2017.5028. Epub 2017 Aug 24.

5.

Friends Turned Foes: Angiogenic Growth Factors beyond Angiogenesis.

Matkar PN, Ariyagunarajah R, Leong-Poi H, Singh KK.

Biomolecules. 2017 Oct 2;7(4). pii: E74. doi: 10.3390/biom7040074. Review.

6.

The anti-vascular endothelial growth factor receptor-1 monoclonal antibody D16F7 inhibits invasiveness of human glioblastoma and glioblastoma stem cells.

Atzori MG, Tentori L, Ruffini F, Ceci C, Lisi L, Bonanno E, Scimeca M, Eskilsson E, Daubon T, Miletic H, Ricci Vitiani L, Pallini R, Navarra P, Bjerkvig R, D'Atri S, Lacal PM, Graziani G.

J Exp Clin Cancer Res. 2017 Aug 10;36(1):106. doi: 10.1186/s13046-017-0577-2.

7.

Prox1-GFP/Flt1-DsRed transgenic mice: an animal model for simultaneous live imaging of angiogenesis and lymphangiogenesis.

Zhong W, Gao X, Wang S, Han K, Ema M, Adams S, Adams RH, Rosenblatt MI, Chang JH, Azar DT.

Angiogenesis. 2017 Nov;20(4):581-598. doi: 10.1007/s10456-017-9572-7. Epub 2017 Aug 9.

PMID:
28795242
8.

Dynamic alterations in decoy VEGF receptor-1 stability regulate angiogenesis.

Boucher JM, Clark RP, Chong DC, Citrin KM, Wylie LA, Bautch VL.

Nat Commun. 2017 Jun 7;8:15699. doi: 10.1038/ncomms15699.

9.

Hsp90β promoted endothelial cell-dependent tumor angiogenesis in hepatocellular carcinoma.

Meng J, Liu Y, Han J, Tan Q, Chen S, Qiao K, Zhou H, Sun T, Yang C.

Mol Cancer. 2017 Mar 31;16(1):72. doi: 10.1186/s12943-017-0640-9.

10.

Motor neurons control blood vessel patterning in the developing spinal cord.

Himmels P, Paredes I, Adler H, Karakatsani A, Luck R, Marti HH, Ermakova O, Rempel E, Stoeckli ET, Ruiz de Almodóvar C.

Nat Commun. 2017 Mar 6;8:14583. doi: 10.1038/ncomms14583.

11.

Angiogenesis in the atherosclerotic plaque.

Camaré C, Pucelle M, Nègre-Salvayre A, Salvayre R.

Redox Biol. 2017 Aug;12:18-34. doi: 10.1016/j.redox.2017.01.007. Epub 2017 Feb 1. Review.

12.

EFFICACY OF INTRAVITREAL AFLIBERCEPT IN MACULAR TELANGIECTASIA TYPE 1 IS LINKED TO THE OCULAR ANGIOGENIC PROFILE.

Kowalczuk L, Matet A, Dirani A, Daruich A, Ambresin A, Mantel I, Spaide RF, Turck N, Behar-Cohen F.

Retina. 2017 Dec;37(12):2226-2237. doi: 10.1097/IAE.0000000000001424.

13.

Thrombospondin-1 as a Paradigm for the Development of Antiangiogenic Agents Endowed with Multiple Mechanisms of Action.

Rusnati M, Urbinati C, Bonifacio S, Presta M, Taraboletti G.

Pharmaceuticals (Basel). 2010 Apr 23;3(4):1241-1278. Review.

14.

Soluble VEGF receptor 1 (sFLT1) induces non-apoptotic death in ovarian and colorectal cancer cells.

Miyake T, Kumasawa K, Sato N, Takiuchi T, Nakamura H, Kimura T.

Sci Rep. 2016 Apr 22;6:24853. doi: 10.1038/srep24853.

15.

A VEGFR1 antagonistic peptide inhibits tumor growth and metastasis through VEGFR1-PI3K-AKT signaling pathway inhibition.

Zhou Z, Zhao C, Wang L, Cao X, Li J, Huang R, Lao Q, Yu H, Li Y, Du H, Qu L, Shou C.

Am J Cancer Res. 2015 Sep 15;5(10):3149-61. eCollection 2015.

16.

VEGF involvement in psoriasis.

Marina ME, Roman II, Constantin AM, Mihu CM, Tătaru AD.

Clujul Med. 2015;88(3):247-52. doi: 10.15386/cjmed-494. Epub 2015 Jul 1. Review.

17.

Nintedanib: evidence for its therapeutic potential in idiopathic pulmonary fibrosis.

Inomata M, Nishioka Y, Azuma A.

Core Evid. 2015 Aug 27;10:89-98. doi: 10.2147/CE.S82905. eCollection 2015. Review.

18.

The cellular response to vascular endothelial growth factors requires co-ordinated signal transduction, trafficking and proteolysis.

Smith GA, Fearnley GW, Tomlinson DC, Harrison MA, Ponnambalam S.

Biosci Rep. 2015 Aug 18;35(5). pii: e00253. doi: 10.1042/BSR20150171. Review.

19.

FLT1 signaling in metastasis-associated macrophages activates an inflammatory signature that promotes breast cancer metastasis.

Qian BZ, Zhang H, Li J, He T, Yeo EJ, Soong DY, Carragher NO, Munro A, Chang A, Bresnick AR, Lang RA, Pollard JW.

J Exp Med. 2015 Aug 24;212(9):1433-48. doi: 10.1084/jem.20141555. Epub 2015 Aug 10.

20.

Inhibition of pathological brain angiogenesis through systemic delivery of AAV vector expressing soluble FLT1.

Shen F, Mao L, Zhu W, Lawton MT, Pechan P, Colosi P, Wu Z, Scaria A, Su H.

Gene Ther. 2015 Nov;22(11):893-900. doi: 10.1038/gt.2015.57. Epub 2015 Jun 19.

Supplemental Content

Support Center